LEVETIRACETAM

USDailyMed:Levetiracetam AU:B3 N03AX14(WHO) AU:S4(Prescription only)BR:Class C1(Other controlled substances)CA:℞-onlyUK:POM(Prescription only)US:℞-onlyEU:Rx-onlyIn general: ℞ (Prescription only) (S)-2-(2-Oxopyrrolidin-1-yl)butanamide 102767-28-2Y 5284583 6826 DB01202N 4447633Y 44YRR34555 D00709Y CHEBI:6437N ChEMBL1286Y DTXSID9023207 Interactive image O=C1N([C@H](C(=O)N)CC)CCC1 InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1YKey:HPHUVLMMVZITSG-LURJTMIES‍​‍‍‍​‍‍‍‍‍‍‍‍​‍A-NY Levetiracetam, sold under the brand nameKeppraamong others, is ananti-seizure medication(medication) used to treatepilepsy.It is used forpartial-onset,myoclonic, ortonic–clonicseizures,and is taken eitherby mouthas animmediateorextended releaseformulation or byinjection into a vein. Common side effects of levetiracetam include sleepiness, dizziness, feeling tired, and aggression.Severe side effects may includepsychosis,suicide, andallergic reactionssuch asStevens–Johnson syndromeoranaphylaxis.Levetiracetam is the S-enantiomerofetiracetam.It acts as asynaptic vesicle glycoprotein 2A(SV2A)ligand. Levetiracetam was approved for medical use in the United States in 1999and is available as ageneric medication.In 2023, it was the 101st most commonly prescribed medication in the United States, with more than 6million prescriptions.It is on theWorld Health Organization's List of Essential Medicinesand among the most commonly prescribed anti-seizure medications in the world.